Michael Mulroy
Chairman chez LINEAGE CELL THERAPEUTICS, INC.
Fortune : 382 661 $ au 31/03/2024
Profil
Michael H.
Mulroy is an Independent Director and Director at Lineage Cell Therapeutics, Inc. and Magtrol, Inc. respectively.
He is also a Trustee at The Pegasus School and the President of Mulroy Advisors LLC.
Previously, he served as the President, Chief Executive Officer & Director at Asterias Biotherapeutics, Inc., an Independent Director at Comarco, Inc., and a Director at AgeX Therapeutics, Inc. He was also an Investment Banker at Citigroup, Inc. and worked as a Partner at Stradling, Yocca Carlson & Rauth PC.
He holds a graduate degree from the University of California, Los Angeles and an undergraduate degree from The University of Chicago.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/07/2023 | 258 555 ( 0,14% ) | 382 661 $ | 31/03/2024 |
Postes actifs de Michael Mulroy
| Sociétés | Poste | Début |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Chairman | 27/04/2024 |
Magtrol, Inc.
 Magtrol, Inc. Electronic Equipment/InstrumentsElectronic Technology Magtrol, Inc. provides measurement and control solutions. It manufactures motor test equipment and hysteresis brakes and clutches. The company was founded in 1953 by John E. Duncan and is headquartered in Buffalo, NY. | Director/Board Member | 11/01/2011 |
Mulroy Advisors LLC
 Mulroy Advisors LLC Miscellaneous Commercial ServicesCommercial Services Mulroy Advisors LLC provides consulting services. The private company is based in Newport Beach, CA. | President | 01/09/2014 |
The Pegasus School
 The Pegasus School Other Consumer ServicesConsumer Services The Pegasus School provides education services. | Director/Board Member | - |
Anciens postes connus de Michael Mulroy
| Sociétés | Poste | Fin |
|---|---|---|
| AGEX THERAPEUTICS, INC. | Director/Board Member | 30/07/2019 |
| ASTERIAS BIOTHERAPEUTICS INC | Chief Executive Officer | 08/03/2019 |
| MALLINCKRODT PLC | General Counsel | 01/09/2014 |
| COMARCO, INC. | Director/Board Member | 25/08/2014 |
| QUESTCOR PHARMACEUTICALS INC | Director of Finance/CFO | 17/02/2014 |
Formation de Michael Mulroy
| University of California, Los Angeles | Graduate Degree |
| The University of Chicago | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| CITIGROUP INC. | Finance |
| MALLINCKRODT PLC | Health Technology |
| Entreprise privées | 9 |
|---|---|
Comarco, Inc.
 Comarco, Inc. Wireless TelecommunicationsCommunications Comarco, Inc. engaged in the development of technologies in the field of power adapters and chargers for portable mobile devices, which included laptop computers and tablets smartphones. The company was founded in 1960 and was headquartered in Laguna Niguel, CA. | Communications |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Stradling, Yocca Carlson & Rauth PC
 Stradling, Yocca Carlson & Rauth PC Miscellaneous Commercial ServicesCommercial Services Stradling, Yocca Carlson & Rauth PC is a private company that has been relied upon by top companies and municipalities for over 40 years. The company is based in Newport Beach, CA. The company has the expertise and team to tackle the toughest challenges around the clock, every day of the year. The company was founded by William R. Rauth. | Commercial Services |
Magtrol, Inc.
Magtrol, Inc. Electronic Equipment/InstrumentsElectronic Technology Magtrol, Inc. provides measurement and control solutions. It manufactures motor test equipment and hysteresis brakes and clutches. The company was founded in 1953 by John E. Duncan and is headquartered in Buffalo, NY. | Electronic Technology |
The Pegasus School
The Pegasus School Other Consumer ServicesConsumer Services The Pegasus School provides education services. | Consumer Services |
| Merrill Lynch & Co., Inc. | Finance |
Mulroy Advisors LLC
Mulroy Advisors LLC Miscellaneous Commercial ServicesCommercial Services Mulroy Advisors LLC provides consulting services. The private company is based in Newport Beach, CA. | Commercial Services |
AgeX Therapeutics, Inc.
 AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. | Health Technology |
